» Articles » PMID: 23260147

A Molecular Roadmap of Reprogramming Somatic Cells into IPS Cells

Abstract

Factor-induced reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is inefficient, complicating mechanistic studies. Here, we examined defined intermediate cell populations poised to becoming iPSCs by genome-wide analyses. We show that induced pluripotency elicits two transcriptional waves, which are driven by c-Myc/Klf4 (first wave) and Oct4/Sox2/Klf4 (second wave). Cells that become refractory to reprogramming activate the first but fail to initiate the second transcriptional wave and can be rescued by elevated expression of all four factors. The establishment of bivalent domains occurs gradually after the first wave, whereas changes in DNA methylation take place after the second wave when cells acquire stable pluripotency. This integrative analysis allowed us to identify genes that act as roadblocks during reprogramming and surface markers that further enrich for cells prone to forming iPSCs. Collectively, our data offer new mechanistic insights into the nature and sequence of molecular events inherent to cellular reprogramming.

Citing Articles

The role of KLF4 in human primordial germ cell development.

Lee S, Pierson Smela M, Surani M Open Biol. 2025; 15(1):240214.

PMID: 39837498 PMC: 11750398. DOI: 10.1098/rsob.240214.


Coordinated repression of totipotency-associated gene loci by histone methyltransferase EHMT2 through binding to LINE-1 regulatory elements.

Chatterjee K, Uyehara C, Kasliwal K, Madhuranath S, Scourzic L, Polyzos A bioRxiv. 2025; .

PMID: 39763795 PMC: 11702699. DOI: 10.1101/2024.12.18.629181.


Reconstitution of pluripotency from mouse fibroblast through Sall4 overexpression.

Xiao L, Huang Z, Wu Z, Yang Y, Zhang Z, Kumar M Nat Commun. 2024; 15(1):10787.

PMID: 39737935 PMC: 11686038. DOI: 10.1038/s41467-024-54924-5.


An Unbiased Approach to Identifying Cellular Reprogramming-Inducible Enhancers.

Klagkou E, Valakos D, Foutadakis S, Polyzos A, Papadopoulou A, Vatsellas G Int J Mol Sci. 2024; 25(23).

PMID: 39684837 PMC: 11642860. DOI: 10.3390/ijms252313128.


Research of reprogramming toward clinical applications in regenerative medicine: A concise review.

Nakatsukasa Y, Yamada Y, Yamada Y Regen Ther. 2024; 28:12-19.

PMID: 39678397 PMC: 11638634. DOI: 10.1016/j.reth.2024.11.008.


References
1.
Stadtfeld M, Hochedlinger K . Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010; 24(20):2239-63. PMC: 2956203. DOI: 10.1101/gad.1963910. View

2.
Sridharan R, Tchieu J, Mason M, Yachechko R, Kuoy E, Horvath S . Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009; 136(2):364-77. PMC: 3273494. DOI: 10.1016/j.cell.2009.01.001. View

3.
Chen J, Liu J, Yang J, Chen Y, Chen J, Ni S . BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res. 2010; 21(1):205-12. PMC: 3193408. DOI: 10.1038/cr.2010.172. View

4.
Huo J, Zambidis E . Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta. 2012; 1830(2):2385-94. PMC: 3552091. DOI: 10.1016/j.bbagen.2012.10.014. View

5.
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K . Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2008; 1(1):55-70. DOI: 10.1016/j.stem.2007.05.014. View